Search
Fasedienol
go.drugbank.com/drugs/DB04968InvestigationalPH94B is being developed by Pherin Pharmaceuticals, Inc. for the treatment of social phobias (generalized anxiety disorder).
Pimicotinib
go.drugbank.com/drugs/DB18972InvestigationalIt was initially developed by Abbisko Therapeutics Co in collaboration with Merck KGaA. [L53748] Pimicotinib was granted Fast Track Designation in December 2023 by the FDA. [L53753]
TTAX01
go.drugbank.com/drugs/DB17928InvestigationalTTAX01 is a cryopreserved human umbilical cord product being developed by TissueTech.[L47246]
Neltenexine
go.drugbank.com/drugs/DB13239InvestigationalNeltenexine is an elastase inhibitor. It may be useful for preventing pulmonary emphysema.
Categories: Cough and Cold PreparationsEfmarodocokin alfa
go.drugbank.com/drugs/DB16398InvestigationalEfmarodocokin alfa is under investigation in clinical trial NCT04386616 (A Study to Evaluate the Safety and Efficacy of MSTT1041A (Astegolimab) or UTTR1147A in Patients With Severe COVID-19 Pneumonia).
Volociximab
go.drugbank.com/drugs/DB06647InvestigationalCategories: Amino Acids, Peptides, and ProteinsSelisistat
go.drugbank.com/drugs/DB13978Investigational, HDAC and NADase respectively). … Selective inhibitor of SIRT1 that does not inhibit histone deacetylase (HDAC) or other sirtuin deacetylase family members (IC50 values are 98, 19600, 48700, > 100000 and > 100000 nM for SIRT1, SIRT2, SIRT3
VIR-5818
go.drugbank.com/drugs/DB28582InvestigationalVIR-5818 is under investigation in clinical trial NCT05356741 (To Access the Safety and Effects of Intravenous Administration of VIR-5818 Alone and in Combination With Pembrolizumab in Adult Participants
Latrepirdine
go.drugbank.com/drugs/DB11725InvestigationalLatrepirdine has been investigated for the treatment of Alzheimer's Disease and Huntington's Disease.